125 related articles for article (PubMed ID: 37244464)
1. ATB
Chen Z; Chen H; Huang L; Duan B; Dai S; Cai W; Sun M; Jiang Z; Lu R; Jiang Y; Jiang X; Zheng H; Yao Q; Kim K; Lin G; Xie C; Chu M; Chen R; Kou L
Int J Pharm; 2023 Jun; 641():123082. PubMed ID: 37244464
[TBL] [Abstract][Full Text] [Related]
2. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
3. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
[TBL] [Abstract][Full Text] [Related]
4. Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel.
Ren Y; Li X; Han B; Zhao N; Mu M; Wang C; Du Y; Wang Y; Tong A; Liu Y; Zhou L; You C; Guo G
Eur J Pharm Sci; 2019 Feb; 128():279-289. PubMed ID: 30553061
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer.
Huang CZ; Zhou Y; Tong QS; Duan QJ; Zhang Q; Du JZ; Yao XQ
Biomaterials; 2022 Nov; 290():121827. PubMed ID: 36228517
[TBL] [Abstract][Full Text] [Related]
6. Resetting amino acid metabolism of cancer cells by ATB
Kou L; Jiang X; Tang Y; Xia X; Li Y; Cai A; Zheng H; Zhang H; Ganapathy V; Yao Q; Chen R
Bioact Mater; 2022 Mar; 9():15-28. PubMed ID: 34820552
[TBL] [Abstract][Full Text] [Related]
7. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor B-MYB activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer.
Liu F; Wang Y; Cao Y; Wu Z; Ma D; Cai J; Sha J; Chen Q
Chem Biol Interact; 2023 Apr; 374():110412. PubMed ID: 36812959
[TBL] [Abstract][Full Text] [Related]
9. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.
Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L
Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471
[TBL] [Abstract][Full Text] [Related]
10. Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly.
Shi Y; Lin G; Zheng H; Mu D; Chen H; Lu Z; He P; Zhang Y; Liu C; Lin Z; Liu G
J Nanobiotechnology; 2021 Dec; 19(1):447. PubMed ID: 34952594
[TBL] [Abstract][Full Text] [Related]
11. A Novel Protein Encoded by Exosomal CircATG4B Induces Oxaliplatin Resistance in Colorectal Cancer by Promoting Autophagy.
Pan Z; Zheng J; Zhang J; Lin J; Lai J; Lyu Z; Feng H; Wang J; Wu D; Li Y
Adv Sci (Weinh); 2022 Dec; 9(35):e2204513. PubMed ID: 36285810
[TBL] [Abstract][Full Text] [Related]
12. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
13. PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.
Yan S; Zhou N; Zhang D; Zhang K; Zheng W; Bao Y; Yang W
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671668
[TBL] [Abstract][Full Text] [Related]
14. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
[TBL] [Abstract][Full Text] [Related]
15. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
[TBL] [Abstract][Full Text] [Related]
16. Nanodrugs Incorporating LDHA siRNA Inhibit M2-like Polarization of TAMs and Amplify Autophagy to Assist Oxaliplatin Chemotherapy against Colorectal Cancer.
Hu L; Huang S; Chen G; Li B; Li T; Lin M; Huang Y; Xiao Z; Shuai X; Su Z
ACS Appl Mater Interfaces; 2022 Jul; 14(28):31625-31633. PubMed ID: 35796429
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the immune landscape and therapeutic biomarker PMEPA1 for oxaliplatin resistance in colorectal cancer: A comprehensive approach.
Zhang Z; Lu T; Zhang Z; Liu Z; Qian R; Qi R; Zhou F; Li M
Biochem Pharmacol; 2024 Apr; 222():116117. PubMed ID: 38461903
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
Gao R; Fang C; Xu J; Tan H; Li P; Ma L
Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
[TBL] [Abstract][Full Text] [Related]
19. SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.
Karunakaran S; Ramachandran S; Coothankandaswamy V; Elangovan S; Babu E; Periyasamy-Thandavan S; Gurav A; Gnanaprakasam JP; Singh N; Schoenlein PV; Prasad PD; Thangaraju M; Ganapathy V
J Biol Chem; 2011 Sep; 286(36):31830-8. PubMed ID: 21771784
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of 5-fluorouracil and oxaliplatin on autophagy in chemoresistant colorectal cancer cells.
Zitkute V; Kukcinaviciute E; Jonusiene V; Starkuviene V; Sasnauskiene A
J Cell Biochem; 2022 Jun; 123(6):1103-1115. PubMed ID: 35490372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
